ACEi to ARNi: “The Switch” An Evidence Based Review
Open Access
- 30 October 2020
- journal article
- Published by Peertechz Publications Private Limited in Journal of Cardiovascular Medicine and Cardiology
- Vol. 7 (3), 288-292
- https://doi.org/10.17352/2455-2976.000154
Abstract
No abstract availableThis publication has 33 references indexed in Scilit:
- Novel Protein Therapeutics for Systolic Heart Failure: Chronic Subcutaneous B-Type Natriuretic PeptideJournal of Invasive Cardiology, 2012
- Prediction of Mode of Death in Heart FailureJournal of the American College of Cardiology, 2007
- BNP Consensus Panel 2004: A Clinical Approach for the Diagnostic, Prognostic, Screening, Treatment Monitoring, and Therapeutic Roles of Natriuretic Peptides in Cardiovascular DiseasesCongestive Heart Failure, 2004
- Plasma A- and B-type natriuretic peptides: physiology, methodology and clinical useCardiovascular Research, 2001
- Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuriaThe Lancet, 1999
- Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)The Lancet, 1997
- Attenuated renal excretory response to atrial natriuretic peptide in congestive heart failure in manInternational Journal of Cardiology, 1991
- Effects of Enalapril on Mortality in Severe Congestive Heart FailureThe New England Journal of Medicine, 1987
- Atrial natriuretic factor in normal subjects and heart failure patients. Plasma levels and renal, hormonal, and hemodynamic responses to peptide infusion.JCI Insight, 1986
- Controlled trial of captopril in chronic heart failure: a rest and exercise hemodynamic study.Journal of the American College of Cardiology, 1983